FDA approved Drugs Collection
A unique library of most diverse drugs
646 compounds
Drug repurposing is a promising field in drug discovery that identifies new therapeutic opportunities for existing drugs (e.g. Viagra and Thalidomide). High-content screens, new biomarkers, and noninvasive imaging techniques have created new capabilities for pursuing novel indications for approved compounds. Hits from this set will provide a significant head start in any drug optimization program.
- Carefully collected and distilled collection of 646 FDA approved drugs
- Supported with full bioactivity annotation, pathway indications and all related chemical structure information (structure, CAS, smiles, molecular parameters)
- NMR and HPLC validated to ensure the highest purity
- Supplied in 96, 384 or 1536-well plates, ready for immediate shipping
- Minimal preparation – just peel, dilute & transfer to assay plate
- Overlap with CLOUD library – 250 compounds
Therapeutic areas
Target distribution
Table of formats
Item
1
Catalog #
FAD-646-Y-2-0
# of compounds
646
Amount
Assay-ready plates, ≤ 150 nL of 2 mM DMSO solution
Plates and format
384-well polypropylene plates, 320 cpds per plate: first and last two columns empty
Item
2
Catalog #
FAD-646-Y-10
# of compounds
646
Amount
10 µL of 10 mM DMSO solution
Plates and format
384-well eco-compatibale plates: first and last columns empty LP200
Item
3
Catalog #
FAD-646-Y/X-50
# of compounds
646
Amount
50 µL of 10 mM DMSO solution
Plates and format
384-well or 96-well plates: first and last columns empty
Item
4
Catalog #
FAD-646-Y/X-100
# of compounds
646
Amount
100 µL of 10 mM DMSO solution
Plates and format
384-well or 96-well plates: first and last columns empty
*Y - 384-well plate *X - 96-well plate